Nxera Pharma Co., Ltd.
SOLTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11 | -$2,377 | -$760 | -$1,335 |
| Dep. & Amort. | $7 | $1,095 | $1,082 | $1,003 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | -$388 | $388 | -$1,025 |
| Change in WC | -$8 | -$2,458 | $2,599 | -$6,736 |
| Other Non-Cash | -$8 | $4,127 | -$2,696 | -$2,877 |
| Operating Cash Flow | -$20 | -$180 | $613 | -$10,970 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$90 | -$109 | -$153 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $89 | $3,706 | -$4,791 |
| Investing Cash Flow | -$0 | -$1 | $3,597 | -$4,944 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10 | -$1,227 | -$1,673 | -$622 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $1,215 | $0 | -$1,052 |
| Financing Cash Flow | -$11 | -$12 | -$1,673 | -$1,674 |
| Forex Effect | -$5 | $13 | -$340 | $988 |
| Net Chg. in Cash | -$37 | -$1 | $34,465 | -$48,868 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $229 | $230 | $0 | $48,868 |
| End Cash | $192 | $229 | $34,465 | $0 |
| Free Cash Flow | -$21 | -$270 | $504 | -$11,123 |